CRITITECH PARTICLE ENGINEERING SOLUTIONS, LLC

CRITITECH PARTICLE ENGINEERING SOLUTIONS, LLC specializes in the design and development of novel drug particles through advanced particle engineering and formulation science. Their core capabilities center on precision particle fabrication, controlled release systems, and physicochemical optimization of active pharmaceutical ingredients for enhanced bioavailability and therapeutic efficacy. The company leverages expertise in spray drying, crystallization, and particle size modulation to deliver tailored drug delivery platforms, with a focus on overcoming solubility and stability challenges in complex therapeutics. Their technical proficiency includes process scale-up, particle characterization via laser diffraction and SEM, and formulation compatibility studies aligned with FDA and DoD pharmaceutical standards. What distinguishes CRITITECH is its focused application of physical chemistry and engineering principles to solve mission-critical drug delivery problems in defense and biomedical contexts. The contractor maintains a consistent relationship with the Department of Defense, delivering research and development solutions for next-generation pharmaceuticals. Their work supports military medical readiness initiatives, including rapid-response therapeutics, stable formulations for field deployment, and novel delivery systems for countermeasures against chemical, biological, and radiological threats. CRITITECH’s primary industry focus is in research and development within the physical and engineering sciences, specifically applied to pharmaceutical particle systems. They occupy a niche in non-biotech, non-nanotech drug development, serving the intersection of materials science and medicinal formulation. This positions them as a specialized provider for defense and federal health agencies seeking non-biological, chemically engineered solutions. As a small business structured as a 2L entity based in Lawrence, Kansas, CRITITECH operates with agility and technical precision. While currently holding no formal government certifications, their work demonstrates deep domain expertise in pharmaceutical engineering, aligning them with high-value defense R&D contracts requiring specialized physical science capabilities.